San Diego, California — According to state and local economic development sources Poseida Therapeutics plans to invest $1,260,932.00 to build out 14,662 square feet of new space in San Diego. The company plans to occupy the new space at 9390 Towne Centre Dr in San Diego, on or about November 1, 2020. According to the company website Poseida Therapeutics is a clinical-stage biotechnology company translating best-in-class technology into lifesaving cell and gene therapies for patients with high unmet medical need. The company is developing CAR T-cell immunotherapies for multiple myeloma, prostate and other cancer types, as well as in vivo gene therapies for orphan genetic diseases. These cell therapies and the gene therapies soon to come are products of our proprietary suite of industry-leading gene engineering technologies.

To learn more about Poseida Therapeutics, visit http://poseida.com/

Company Contact:
Eric Ostertag, Chief Executive Officer
ostertag@poseida.com
https://www.linkedin.com/in/ericostertag/
858-779-3100

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved